INTERACTIONS OF SPRIONOLACTONE WITH HEPATIC MICROSOMAL DRUG-METABOLIZING ENZYME SYSTEMS

被引：44

作者：

FELLER, DR

GERALD, MC

机构：

来源：

关键词：

D O I：

10.1016/0006-2952(71)90398-4

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1991 / &

共 22 条

[1]

CONNEY AH, 1967, PHARMACOL REV, V19, P317

[2]

COOPER JR, 1955, J PHARMACOL EXP THER, V114, P409

DAVIES, DS ;

GIGON, PL ;

GILLETTE, JR .

LIFE SCIENCES PART 1 PHYSIOLOGY AND PHARMACOLOGY AND PART 2 BIOCHEMISTRY GENERAL AND MOLECULAR BIOLOGY, 1969, 8 (2P2) :85-&

[4]

GERALD MC, 1970, PHARMACOLOGIST, V12, P279

GERALD, MC ;

FELLER, DR .

[6]

GIGON PL, 1969, MOL PHARMACOL, V5, P109

GIGON, PL ;

GRAM, TE ;

GILLETTE, JR .

[8]

Gillette J R, 1966, Adv Pharmacol, V4, P219, DOI 10.1016/S1054-3589(08)60100-3

[9]

GILLETTE JR, 1969, MICROSOMES DRUG OXID, P133

[10]

HERTZ R, 1958, P SOC EXP BIOL MED, V99, P451